IART Integra LifeSciences Holdings Corporation - Common Stock
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 七月 29, 2026IART 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
IART 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2017年1月4日 | 2-for-1 | 正向 |
| 1998年5月26日 | 1-for-2 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
| 指标 | 5年趋势 | IART | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -126.85年均值 ≈-28.4 | ≈-28.4 | · | · |
同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | IART | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 4.0%5年均值 ≈1.4% | ≈1.4% | 1.9% | 顶尖 | |
| EBITDA Margin (息税折旧摊销前利润率) | -30.2%5年均值 ≈1.4% | ≈1.4% | 1.9% | 顶尖 | |
| 税前利润率 (TTM) | -0.01%5年均值 ≈-0.54% | ≈-0.54% | 1.1% | 持平 | |
| 净利润率 (TTM) | -0.44%5年均值 ≈-1.0% | ≈-1.0% | -3.6% | 顶尖 | |
| ROA (TTM) | -0.20%5年均值 ≈-0.53% | ≈-0.53% | -6.7% | 低于平均水平 | |
| ROE (TTM) | -0.70%5年均值 ≈-5.1% | ≈-5.1% | -12.3% | 弱 | |
| ROIC | -43.3%5年均值 ≈-3.3% | ≈-3.3% | 0.08% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | IART | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 3.65年均值 ≈2.8 | ≈2.8 | 3.3 | 持平 | |
| 速动比率 (MRQ) | 1.65年均值 ≈1.6 | ≈1.6 | 1.6 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | IART | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 1.5%5年均值 ≈3.7% | ≈3.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 1.6%5年均值 ≈2.3% | ≈2.3% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 3.6% | · | · | · | |
| EPS YoY | -61.1%5年均值 ≈-8.6% | ≈-8.6% | · | · | |
| Net Income YoY (净利润同比增长) | -62.5%5年均值 ≈-9.8% | ≈-9.8% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率(3年)) | -18.8% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率(3年)) | -20.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | IART | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.45年均值 ≈0.4 | ≈0.4 | 0.6 | 弱 | |
| Inventory Turnover (库存周转率) | 1.75年均值 ≈1.8 | ≈1.8 | 1.8 | 弱 | |
| Receivables Turnover (应收账款周转率) | 5.95年均值 ≈6.2 | ≈6.2 | 6.4 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数(报告的 headcount,yfinance)。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$369.4K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 七月 29, 2026 | $0.56 | $0.49 | 13.6% |
| 2026年3月31日 | $0.54 | $0.41 | 30.9% | |
| 2025年12月31日 | $0.83 | $0.82 | 1.7% | |
| 2025年9月30日 | $0.54 | $0.44 | 21.7% | |
| 2025年6月30日 | $0.45 | $0.44 | 2.2% | |
| 2025年3月31日 | $0.41 | $0.44 | -6.8% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B | $1.37B | $1.52B | $1.47B | $1.19B | $992M | $883M | $797M | |
| Cost of Revenue | $804M | $728M | $657M | $587M | $598M | $521M | $565M | $571M | $436M | $349M | $327M | $303M | |
| Gross Profit | · | · | · | · | · | $851M | $953M | $901M | $753M | $643M | $556M | $494M | |
| R&D Expense | · | · | · | · | · | · | · | $78M | $63M | $58M | $51M | $44M | |
| SG&A Expense | $700M | $717M | $657M | $616M | $637M | $595M | $688M | $691M | $624M | $456M | $416M | $376M | |
| Operating Expenses | $2.13B | $1.58B | $1.43B | $1.32B | $1.35B | $1.22B | $1.42B | $1.36B | $1.14B | $877M | $803M | $729M | |
| Operating Income | $-493M | $28M | $112M | $239M | $197M | $151M | $94M | $111M | $45M | $115M | $80M | $68M | |
| Interest Expense | · | · | $51M | $50M | $50M | $72M | $54M | $65M | $35M | $26M | $24M | $22M | |
| Interest Income | $18M | $20M | $17M | $12M | $7M | $9M | $11M | $3M | $255.0K | $24.0K | $30.0K | $168.0K | |
| Other Non-op | $-2M | $4M | $4M | $12M | $19M | $4M | $10M | $8M | $1M | $845.0K | $5M | $-492.0K | |
| Pretax Income | $-564M | $-18M | $81M | $214M | $215M | $94M | $60M | $57M | $11M | $90M | $61M | $46M | |
| Income Tax | $-47M | $-11M | $13M | $33M | $46M | $-40M | $10M | $-3M | $-53M | $16M | $54M | $9M | |
| Net Income | $-516M | $-7M | $68M | $181M | $169M | $134M | $50M | $61M | $65M | $75M | $-4M | $34M | |
| EPS (Basic) | $-6.74 | $-0.09 | $0.85 | $2.18 | $2.00 | $1.58 | $0.59 | $0.73 | $0.84 | $1.00 | $-0.05 | $0.52 | |
| EPS (Diluted) | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 | $1.57 | $0.58 | $0.72 | $0.82 | $0.94 | $-0.05 | $0.52 | |
| Shares (Basic) | 76,672,000 | 77,010,000 | 80,089,000 | 82,997,000 | 84,698,000 | 84,650,000 | 85,637,000 | 82,857,000 | 76,897,000 | 74,386,000 | 68,990,000 | 64,864,000 | |
| Shares (Diluted) | 76,672,000 | 77,010,000 | 80,337,000 | 83,516,000 | 85,485,000 | 85,228,000 | 86,494,000 | 83,999,000 | 79,121,000 | 79,194,000 | 71,354,000 | 65,920,000 | |
| EBITDA | $-493M | $28M | $112M | $239M | $197M | $151M | $203M | $222M | $134M | $188M | $138M | $127M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $235M | $246M | $276M | $457M | $513M | $470M | $199M | $139M | $175M | $102M | $48M | $72M | |
| Short-term Investments | $29M | $27M | $33M | $0 | · | · | · | · | · | $0 | · | · | |
| Receivables | $279M | $272M | $259M | $263M | $232M | $226M | $275M | $266M | $252M | $148M | $132M | $110M | |
| Inventory | $493M | $429M | $390M | $325M | $317M | $310M | $316M | $280M | $296M | $217M | $211M | $189M | |
| Prepaid Expense | $96M | $77M | $67M | $86M | $91M | $69M | $68M | $90M | $99M | $28M | $43M | $28M | |
| Other Current Assets | $28M | $30M | $33M | $31M | · | · | · | · | · | · | · | · | |
| Current Assets | $1.16B | $1.08B | $1.06B | $1.16B | $1.15B | $1.24B | $858M | $775M | $822M | $495M | $438M | $529M | |
| PP&E (Net) | $444M | $406M | $340M | $311M | $312M | $288M | $337M | $300M | $269M | $222M | $205M | $194M | |
| PP&E (Gross) | $888M | $803M | $708M | $641M | $627M | $570M | $622M | $555M | $489M | $413M | $374M | $341M | |
| Accum. Depreciation | $444M | $397M | $367M | $330M | $315M | $283M | $285M | $255M | $220M | $191M | $169M | $147M | |
| Goodwill | $615M | $1.10B | $1.06B | $1.04B | $1.01B | $932M | $954M | $926M | $938M | $511M | $512M | $363M | |
| Intangibles | $1.13B | $1.21B | $1.07B | $1.13B | $1.15B | $989M | $1.03B | $1.08B | $1.16B | $561M | $604M | $413M | |
| Other Non-current Assets | $38M | $67M | $58M | $57M | $16M | $11M | $15M | $20M | $16M | $12M | $7M | $10M | |
| Total Assets | $3.60B | $4.04B | $3.78B | $3.89B | $3.78B | $3.62B | $3.30B | $3.11B | $3.21B | $1.81B | $1.77B | $1.59B | |
| Accrued Liabilities | $130M | $122M | $101M | $80M | $120M | $94M | $77M | $85M | $88M | $35M | $39M | $40M | |
| Current Liabilities | $456M | $922M | $307M | $321M | $340M | $401M | $331M | $263M | $349M | $124M | $139M | $126M | |
| Capital Leases | $163M | $167M | $167M | $157M | $90M | $88M | $98M | · | · | · | · | · | |
| Deferred Tax | $6M | $61M | $35M | $63M | $46M | $16M | $37M | $58M | $65M | $149M | $155M | $100M | |
| Other Non-current Liabilities | $204M | $146M | $200M | $139M | $120M | $187M | $118M | $80M | $54M | $31M | $29M | $28M | |
| Total Liabilities | $2.56B | $2.49B | $2.19B | $2.09B | $2.10B | $2.10B | $1.89B | $1.73B | $2.25B | $968M | $1.02B | $883M | |
| Long-term Debt | $727M | $760M | $775M | $775M | $844M | $878M | $878M | $900M | · | · | · | · | |
| Common Stock | $923.0K | $916.0K | $909.0K | $905.0K | $896.0K | $893.0K | $887.0K | $880.0K | $813.0K | $777.0K | $917.0K | $416.0K | |
| Retained Earnings | $423M | $940M | $947M | $879M | $699M | $532M | $399M | $348M | $285M | $220M | $146M | $315M | |
| Treasury Stock | $689M | $691M | $647M | $363M | $234M | $235M | $120M | $121M | $122M | $123M | $367M | $367M | |
| AOCI | $-30M | $-28M | $-15M | $10M | $-45M | $-74M | $-76M | $-45M | $-24M | $-57M | $-48M | $-23M | |
| Stockholders' Equity | $1.04B | $1.55B | $1.59B | $1.80B | $1.68B | $1.51B | $1.42B | $1.38B | $962M | $840M | $751M | $704M | |
| Liabilities + Equity | $3.60B | $4.04B | $3.78B | $3.89B | $3.78B | $3.62B | $3.30B | $3.11B | $3.21B | $1.81B | $1.77B | $1.59B | |
| Shares Outstanding | · | · | · | · | 89,600,000 | 89,251,000 | · | · | · | · | · | · |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $109M | $111M | $89M | $73M | $59M | $46M | |
| Stock-based Comp | $19M | $24M | $20M | $28M | $36M | $20M | $21M | $21M | $22M | $17M | $15M | $15M | |
| Deferred Tax | $-66M | $-21M | $-12M | $-5M | $-3M | $-64M | $-19M | $-8M | $-67M | $-6M | $-351.0K | $-7M | |
| Amort. of Intangibles | $15M | $21M | $12M | $14M | $17M | $28M | $27M | $21M | $20M | $14M | $10M | $7M | |
| Other Non-cash | · | · | · | · | · | · | $70M | $16M | $7M | $-42M | $24M | $-30M | |
| Operating Cash Flow | $50M | $129M | $140M | $264M | $312M | $204M | $231M | $200M | $115M | $116M | $105M | $84M | |
| CapEx | $81M | $104M | $67M | $42M | $48M | $39M | $70M | $78M | $44M | $47M | $33M | $38M | |
| Investing Cash Flow | $-108M | $-391M | $-94M | $-59M | $-161M | $-68M | $-163M | $-50M | $-1.22B | $-43M | $-372M | $-363M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $350M | $0 | $0 | $220M | $0 | |
| Stock Repurchased | $221.0K | $52M | $275M | $125M | $0 | $100M | $0 | $0 | · | · | · | · | |
| Net Stock Activity | $-221.0K | $-52M | $-275M | $-125M | $0 | $-100M | $0 | $350M | $0 | $0 | $220M | $0 | |
| Financing Cash Flow | $28M | $238M | $-230M | $-252M | $-98M | $122M | $-9M | $-181M | $1.17B | $-15M | $248M | $239M | |
| Net Change in Cash | $-11M | $-30M | $-180M | $-57M | $43M | $271M | $60M | $-36M | $73M | $54M | $-24M | $-49M | |
| Taxes Paid | $17M | $23M | $24M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-31M | $25M | $73M | $222M | $264M | $165M | $162M | $122M | $71M | $69M | $61M | $38M | |
| Levered FCF | · | · | $30M | $180M | $225M | $62M | $117M | $53M | $-128M | $48M | $58M | $20M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 62.0% | 62.8% | 61.2% | 63.3% | 64.8% | 63.0% | · | |
| Operating Margin | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% | 11.0% | 6.2% | 7.5% | 3.8% | 11.6% | 9.0% | 7.1% | |
| Net Margin | -31.6% | -0.43% | 4.4% | 11.6% | 11.0% | 9.8% | 3.3% | 4.1% | 5.5% | 7.5% | -0.40% | 3.7% | |
| Pretax Margin | -34.5% | -1.1% | 5.3% | 13.7% | 13.9% | 6.8% | 4.0% | 3.9% | 0.96% | 9.1% | 6.9% | 4.6% | |
| EBITDA Margin | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% | 11.0% | 13.4% | 15.1% | 11.3% | 18.9% | 15.7% | 13.7% | |
| ROA | -13.5% | -0.18% | 1.8% | 4.7% | 4.6% | 3.9% | 1.6% | 1.9% | 2.6% | 4.2% | -0.21% | 2.5% | |
| ROE | -49.6% | -0.45% | 4.3% | 10.2% | 10.2% | 9.2% | 3.6% | 4.4% | 6.9% | 9.4% | -0.48% | 5.0% | |
| ROIC | -43.3% | 0.70% | 5.9% | 11.2% | 9.2% | 14.3% | 5.5% | 8.6% | 26.5% | 11.3% | 1.2% | 7.4% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 1.2 | 3.4 | 3.6 | 3.4 | 3.1 | 2.6 | 3.0 | 2.4 | 4.0 | 3.2 | 4.2 | |
| Quick Ratio | 1.2 | 0.6 | 1.9 | 2.2 | 2.2 | 1.7 | 1.4 | 1.5 | 1.2 | 2.0 | 1.3 | 1.6 | |
| Interest Coverage | · | · | 2.2 | 4.8 | 3.9 | 2.1 | 1.7 | 1.7 | 1.3 | 4.5 | 3.4 | 3.0 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.7 | |
| Inventory Turnover | 1.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.7 | 1.9 | 2.0 | 1.7 | 1.6 | 1.6 | 1.6 | |
| Receivables Turnover | 5.9 | 6.1 | 5.9 | 6.3 | 6.7 | 5.5 | 5.6 | 5.7 | 5.9 | 7.1 | 7.3 | 7.4 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $21.33 | $20.91 | $19.19 | $18.65 | $18.04 | $16.10 | $17.55 | $17.53 | $15.02 | $12.53 | $24.74 | $28.16 | |
| Cash Flow / Share | $0.66 | $1.68 | $1.74 | $3.17 | $3.65 | $2.39 | $2.68 | $2.38 | $1.45 | $1.47 | $2.65 | $2.41 | |
| EPS (TTM) | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 | $1.57 | $0.58 | $0.72 | $0.82 | $0.94 | $-0.05 | $0.52 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1.5% | 4.5% | -1.0% | 0.99% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.6% | 1.5% | 4.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -61.1% | 9.1% | 26.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | -18.8% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -62.5% | 6.8% | 26.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | -20.3% | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B | $1.37B | $1.52B | $1.47B | $1.19B | $992M | $883M | $797M | |
| Net Income TTM | $-516M | $-7M | $68M | $181M | $169M | $134M | $50M | $61M | $65M | $75M | $-4M | $34M | |
| P/E | -1.8 | -252.0 | 51.8 | 26.0 | 33.8 | 41.4 | 100.5 | 62.6 | 58.4 | 45.6 | -677.8 | 47.1 | |
| Earnings Yield | -54.3% | -0.40% | 1.9% | 3.9% | 3.0% | 2.4% | 1.0% | 1.6% | 1.7% | 2.2% | -0.15% | 2.1% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $419M | $392M | $435M | $402M | $416M | $383M | $443M | $381M | $418M | $369M | $397M | $382M | $381M | $381M | $398M | $385M | |
| Cost of Revenue | $199M | $175M | $214M | $195M | $206M | $188M | $194M | $181M | $192M | $162M | $171M | $164M | $174M | $148M | $148M | $148M | |
| SG&A Expense | $172M | $178M | $169M | $169M | $180M | $181M | $179M | $177M | $195M | $166M | $163M | $162M | $165M | $167M | $152M | $144M | |
| Operating Expenses | $399M | $380M | $412M | $390M | $928M | $398M | $407M | $389M | $421M | $365M | $361M | $356M | $369M | $344M | $330M | $320M | |
| Operating Income | $19M | $11M | $23M | $12M | $-513M | $-15M | $36M | $-8M | $-3M | $4M | $36M | $27M | $13M | $36M | $68M | $65M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $14M | · | $13M | $12M | $12M | · | $13M | |
| Interest Income | $4M | $4M | $4M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $3M | |
| Other Non-op | $4M | $4M | $581.0K | $-842.0K | $-2M | $-144.0K | $1M | $2M | $1M | $-610.0K | $2M | $471.0K | $-155.0K | $1M | $4M | $3M | |
| Pretax Income | $5M | $-2M | $4M | $-7M | $-531M | $-30M | $23M | $-20M | $-15M | $-5M | $29M | $19M | $4M | $30M | $64M | $59M | |
| Income Tax | $262.0K | $2M | $6M | $-1M | $-47M | $-5M | $3M | $-10M | $-3M | $-2M | $9M | $-888.0K | $-360.0K | $6M | $11M | $9M | |
| Net Income | $4M | $-5M | $-2M | $-5M | $-484M | $-25M | $19M | $-11M | $-12M | $-3M | $20M | $19M | $4M | $24M | $53M | $50M | |
| EPS (Basic) | $0.06 | $-0.06 | $-0.03 | $-0.07 | $-6.31 | $-0.33 | $0.25 | $-0.14 | $-0.16 | $-0.04 | $0.26 | $0.24 | $0.05 | $0.30 | $0.65 | $0.60 | |
| EPS (Diluted) | $0.06 | $-0.06 | $-0.03 | $-0.07 | $-6.31 | $-0.33 | $0.25 | $-0.14 | $-0.16 | $-0.04 | $0.26 | $0.24 | $0.05 | $0.29 | $0.63 | $0.60 | |
| Shares (Basic) | 77,293,000 | 76,951,000 | · | 76,753,000 | 76,695,000 | 76,463,000 | · | 76,448,000 | 77,409,000 | 77,735,000 | · | 79,690,000 | 80,966,000 | 81,871,000 | · | 83,042,000 | |
| Shares (Diluted) | 78,168,000 | 76,951,000 | · | 76,753,000 | 76,695,000 | 76,463,000 | · | 76,448,000 | 77,409,000 | 77,735,000 | · | 79,811,000 | 81,151,000 | 82,323,000 | · | 83,399,000 | |
| EBITDA | $19M | $11M | · | $12M | $-513M | $-15M | · | $-8M | $-3M | $4M | · | $27M | $13M | $36M | · | $65M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $237M | $235M | $232M | $218M | $239M | $246M | $215M | $215M | $592M | · | $274M | $309M | $307M | · | $512M | |
| Short-term Investments | $60M | $29M | $29M | $36M | $36M | $34M | $27M | $62M | $82M | $71M | · | · | · | · | · | · | |
| Receivables | $267M | $264M | $279M | $262M | $285M | $252M | $272M | $248M | $271M | $241M | · | $256M | $259M | $254M | · | $248M | |
| Inventory | $492M | $495M | $493M | $489M | $465M | $445M | $429M | $437M | $422M | $403M | · | $366M | $354M | $351M | · | $311M | |
| Prepaid Expense | $104M | $98M | $96M | $94M | $103M | $104M | $77M | $86M | $94M | $73M | · | $131M | $129M | $117M | · | $123M | |
| Other Current Assets | $54M | $49M | $28M | $30M | $36M | $32M | $30M | $50M | $29M | $35M | · | · | · | · | · | · | |
| Current Assets | $1.19B | $1.17B | $1.16B | $1.14B | $1.14B | $1.11B | $1.08B | $1.10B | $1.11B | $1.42B | · | $1.03B | $1.05B | $1.03B | · | $1.20B | |
| PP&E (Net) | $446M | $447M | $444M | $437M | $435M | $423M | $406M | $391M | $374M | $345M | · | $319M | $318M | $315M | · | $301M | |
| PP&E (Gross) | · | · | $888M | · | · | · | $803M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $444M | · | · | · | $397M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $611M | $613M | $615M | $615M | $616M | $1.11B | $1.10B | $1.12B | $1.10B | $1.04B | $1.06B | $1.04B | $1.04B | $1.04B | $1.04B | $978M | |
| Intangibles | $1.08B | $1.11B | $1.13B | $1.16B | $1.19B | $1.19B | $1.21B | $1.21B | $1.22B | $1.02B | · | $1.07B | $1.09B | $1.11B | · | $1.05B | |
| Other Non-current Assets | $32M | $35M | $38M | $42M | $46M | $53M | $67M | $54M | $71M | $68M | · | $78M | $67M | $56M | · | $78M | |
| Total Assets | $3.56B | $3.58B | $3.60B | $3.65B | $3.67B | $4.05B | $4.04B | $4.07B | $4.07B | $4.08B | · | $3.74B | $3.78B | $3.74B | · | $3.81B | |
| Accrued Liabilities | $108M | $133M | $130M | $133M | $131M | $137M | $122M | $132M | $102M | $112M | · | $90M | $95M | $93M | · | $79M | |
| Current Liabilities | $331M | $347M | $456M | $364M | $930M | $918M | $922M | $913M | $328M | $302M | · | $356M | $377M | $282M | · | $304M | |
| Capital Leases | $163M | $160M | $163M | $161M | $159M | $161M | $167M | $168M | $170M | $170M | · | $168M | $160M | $157M | · | $158M | |
| Deferred Tax | $3M | $6M | $6M | $58M | $60M | $58M | $61M | $69M | $87M | $31M | · | $74M | $71M | $62M | · | $70M | |
| Other Non-current Liabilities | $194M | $196M | $204M | $233M | $253M | $160M | $146M | $190M | $155M | $140M | · | $142M | $153M | $127M | · | $64M | |
| Total Liabilities | $2.52B | $2.54B | $2.56B | $2.61B | $2.63B | $2.53B | $2.49B | $2.54B | $2.54B | $2.48B | · | $2.16B | $2.09B | $2.07B | · | $2.08B | |
| Long-term Debt | $707M | $717M | $727M | $736M | $746M | $756M | · | $765M | $770M | $775M | · | $775M | $775M | $775M | · | $810M | |
| Common Stock | $921.0K | $922.0K | $923.0K | $923.0K | $923.0K | $921.0K | $916.0K | $916.0K | $916.0K | $915.0K | · | $909.0K | $909.0K | $908.0K | · | $903.0K | |
| Retained Earnings | $423M | $419M | $423M | $425M | $431M | $915M | $940M | $920M | $931M | $944M | · | $927M | $908M | $903M | · | $826M | |
| Treasury Stock | $687M | $687M | $689M | $690M | $690M | $690M | $691M | $692M | $681M | $646M | · | $613M | $514M | $482M | · | $363M | |
| AOCI | $-40M | $-31M | $-30M | $-32M | $-31M | $-24M | $-28M | $-25M | $-19M | $-11M | · | $2M | $5M | $7M | · | $-7M | |
| Stockholders' Equity | $1.04B | $1.04B | $1.04B | $1.04B | $1.04B | $1.52B | $1.55B | $1.52B | $1.53B | $1.60B | $1.59B | $1.58B | $1.68B | $1.67B | $1.80B | $1.72B | |
| Liabilities + Equity | $3.56B | $3.58B | $3.60B | $3.65B | $3.67B | $4.05B | $4.04B | $4.07B | $4.07B | $4.08B | · | $3.74B | $3.78B | $3.74B | · | $3.81B | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 90,341,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $6M | $6M | $5M | $2M | $7M | $4M | $7M | $6M | $6M | $5M | $5M | $4M | $6M | $9M | |
| Deferred Tax | $-4M | $1M | $-11M | $-9M | $-45M | $-2M | $-7M | $-9M | $-2M | $-3M | $-15M | $1M | $-227.0K | $2M | $-6M | $-6M | |
| Amort. of Intangibles | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $10M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Operating Cash Flow | $23M | $10M | $12M | $41M | $9M | $-11M | $51M | $22M | $40M | $16M | $59M | $27M | $28M | $26M | $85M | $68M | |
| CapEx | $12M | $15M | $17M | $15M | $20M | $29M | $30M | $30M | $30M | $15M | $25M | $13M | $16M | $14M | $14M | $9M | |
| Investing Cash Flow | $-43M | $-15M | $-35M | $-16M | $-22M | $-36M | $-4M | $-10M | $-322M | $-54M | $-57M | $-8M | $-16M | $-14M | $-55M | $15M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $2M | $0 | $50M | $0 | $0 | $125M | $0 | $150M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-150M | · | · | |
| Financing Cash Flow | $-818.0K | $8M | $24M | $-10M | $-21M | $35M | $-7M | $-20M | $-94M | $359M | $-7M | $-50M | $-11M | $-163M | $-98M | $-8M | |
| Net Change in Cash | $-22M | $2M | $3M | $14M | $-21M | $-7M | $31M | $-79.0K | $-377M | $316M | $3M | $-35M | $2M | $-149M | $-55M | $65M | |
| Free Cash Flow | · | $-5M | · | · | · | $-40M | · | · | · | $291.0K | · | · | · | $12M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | $3M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.6% | 2.9% | · | 2.9% | -123.4% | -4.0% | · | -2.1% | -0.72% | 1.1% | · | 7.0% | 3.3% | 9.6% | · | 16.9% | |
| Net Margin | 1.1% | -1.2% | · | -1.3% | -116.5% | -6.6% | · | -2.8% | -3.0% | -0.89% | · | 5.1% | 1.1% | 6.4% | · | 13.0% | |
| Pretax Margin | 1.1% | -0.61% | · | -1.7% | -127.8% | -7.8% | · | -5.3% | -3.6% | -1.4% | · | 4.9% | 1.0% | 7.8% | · | 15.3% | |
| EBITDA Margin | 4.6% | 2.9% | · | 2.9% | -123.4% | -4.0% | · | -2.1% | -0.72% | 1.1% | · | 7.0% | 3.3% | 9.6% | · | 16.9% | |
| ROA | 0.12% | -0.12% | · | -0.14% | -12.5% | -0.62% | · | -0.27% | -0.32% | -0.08% | · | 0.52% | 0.11% | 0.65% | · | 1.3% | |
| ROE | 0.43% | -0.36% | · | -0.42% | -37.6% | -1.6% | · | -0.69% | -0.77% | -0.20% | · | 1.2% | 0.25% | 1.5% | · | 3.0% | |
| ROIC | 1.8% | 2.1% | · | 0.90% | -45.0% | -0.86% | · | -0.28% | -0.16% | 0.16% | · | 1.8% | 0.81% | 1.8% | · | 3.2% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.4 | · | 3.1 | 1.2 | 1.2 | · | 1.2 | 3.4 | 4.7 | · | 2.9 | 2.8 | 3.6 | · | 3.9 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.5 | 0.6 | 0.6 | · | 0.6 | 1.7 | 3.0 | · | 1.5 | 1.5 | 2.0 | · | 2.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 0.3 | · | 2.0 | 1.0 | 3.0 | · | 5.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | |
| Receivables Turnover | 1.5 | 1.5 | · | 1.6 | 1.5 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.6 | · | 1.6 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $19.09 | |
| Revenue / Share | $5.36 | $5.09 | · | $5.24 | $5.42 | $5.00 | · | $4.98 | $5.40 | $4.75 | · | $4.79 | $4.70 | $4.63 | · | $4.62 | |
| Cash Flow / Share | · | $0.13 | · | · | · | $-0.15 | · | · | · | $0.20 | · | · | · | $0.32 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5.67 | |
| EPS (TTM) | $-0.10 | $-6.47 | · | $-6.46 | $-6.53 | $-0.38 | · | $-0.08 | $0.30 | $0.51 | · | $1.21 | $1.57 | $2.06 | · | $2.06 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.65B | $1.64B | · | $1.64B | $1.62B | $1.62B | · | $1.56B | $1.57B | $1.53B | · | $1.54B | $1.55B | $1.56B | · | $1.57B | |
| Net Income TTM | $-7M | $-496M | · | $-495M | $-501M | $-29M | · | $-7M | $24M | $40M | · | $101M | $131M | $172M | · | $173M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.83B | |
| P/E | -179.6 | -1.5 | · | -2.2 | -1.9 | -57.9 | · | -227.1 | 97.1 | 69.5 | · | 31.6 | 26.2 | 27.9 | · | 20.6 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.2 | |
| Earnings Yield | -0.56% | -68.7% | · | -45.1% | -53.2% | -1.7% | · | -0.44% | 1.0% | 1.4% | · | 3.2% | 3.8% | 3.6% | · | 4.9% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B |
| 营业利润率 % | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% |
| 净收入 | $-516M | $-7M | $68M | $181M | $169M |
| 稀释后每股收益 (EPS) | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 2.5 | 1.2 | 3.4 | 3.6 | 3.4 |
| 速动比率 | 1.2 | 0.6 | 1.9 | 2.2 | 2.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-31M | $25M | $73M | $222M | $264M |
机构持有人 (13F) 222 家申报者 · $1.4B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 42 (+3 与上一季度对比) | 31 (+2 与上一季度对比) | 73 (+13 与上一季度对比) | 59 (-8 与上一季度对比) | +1.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $191886488 | 10684103 | 13.49% | 股份 |
| Rubric Capital Management LP | $139260655 | 7753934 | 9.79% | 股份 |
| VANGUARD GROUP INC | $89555950 | 7210624 | 6.30% | 股份 |
| Invesco Ltd. | $67338631 | 3749367 | 4.73% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $67225950 | 3743093 | 4.73% | 股份 |
| MORGAN STANLEY | $64531722 | 3593079 | 4.54% | 股份 |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $61766200 | 3439098 | 4.34% | 股份 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $61710664 | 3436006 | 4.34% | 股份 |
| STATE STREET CORP | $52925642 | 2946862 | 3.72% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $52913267 | 2946173 | 3.72% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $42626533 | 2364777 | 3.00% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $39814517 | 2216653 | 2.80% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $32183715 | 1791635 | 2.26% | 股份 |
| GOLDMAN SACHS GROUP INC | $26467994 | 1473719 | 1.86% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $26241429 | 1461104 | 1.85% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $25857856 | 1439747 | 1.82% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25170509 | 1401476 | 1.77% | 股份 |
| BANK OF AMERICA CORP /DE/ | $23873348 | 1329251 | 1.68% | 股份 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $18377461 | 1023243 | 1.29% | 股份 |
| Allianz Asset Management GmbH | $18053446 | 1005203 | 1.27% | 股份 |
| GLENMEDE TRUST CO NA | $17028630 | 948142 | 1.20% | 股份 |
| NORTHERN TRUST CORP | $14880435 | 828532 | 1.05% | 股份 |
| Glenmede Investment Management, LP | $12072021 | 842430 | 0.85% | 股份 |
| Balyasny Asset Management L.P. | $11506361 | 640666 | 0.81% | 股份 |
| Quantinno Capital Management LP | $10940011 | 609132 | 0.77% | 股份 |
| Kent Lake PR LLC | $10777392 | 752086 | 0.76% | 股份 |
| Invenomic Capital Management LP | $10399487 | 579036 | 0.73% | 股份 |
| Integral Health Asset Management, LLC | $9878000 | 550000 | 0.69% | 股份 |
| D. E. Shaw & Co., Inc. | $9110246 | 507252 | 0.64% | 股份 |
| Bank of New York Mellon Corp | $8722669 | 485672 | 0.61% | 股份 |
| Nuveen, LLC | $8718826 | 485458 | 0.61% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $7952311 | 442779 | 0.56% | 股份 |
| DEUTSCHE BANK AG\ | $7819048 | 435359 | 0.55% | 股份 |
| Access Investment Management LLC | $7273836 | 405002 | 0.51% | 股份 |
| Leeward Investments, LLC - MA | $6288730 | 350152 | 0.44% | 股份 |
| MARSHALL WACE, LLP | $6281277 | 349737 | 0.44% | 股份 |
| PFM Health Sciences, LP | $6263478 | 348746 | 0.44% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $5982476 | 333100 | 0.42% | 股份 |
| Legal & General Group Plc | $5918700 | 329549 | 0.42% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $5807958 | 323383 | 0.41% | 股份 |
| KOTLER KEVIN | $5308867 | 427445 | 0.37% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $4929319 | 274461 | 0.35% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $4636535 | 258159 | 0.33% | 股份 |
| FRANKLIN RESOURCES INC | $4141180 | 230578 | 0.29% | 股份 |
| Public Sector Pension Investment Board | $4128788 | 229888 | 0.29% | 股份 |
| JPMORGAN CHASE & CO | $4019805 | 214504 | 0.28% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $3321792 | 184955 | 0.23% | 股份 |
| RHUMBLINE ADVISERS | $3075898 | 171265 | 0.22% | 股份 |
| Vanguard Global Advisers, LLC | $3018968 | 168094 | 0.21% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $2736583 | 152371 | 0.19% | 股份 |
激进投资者及 5%+ 股东 9 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Stuart M. Essig ×5 申报 | 2015年5月11日 | · | 初始申报 | · | SEC |
| Stuart M. Essig (2) | 2012年10月29日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2008年1月4日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2007年6月19日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2006年12月6日 | · | 初始申报 | · | SEC |
| QUANTUM INDUSTRIAL PARTNERS LDC, QIH MANAGEMENT INVESTOR, L.P., QIH MANAGEMENT LLC, SOROS FUND MANAGEMENT LLC, GEORGE SOROS (in the capacity described herein) ×10 申报 | 2006年4月4日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2006年1月31日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2006年1月4日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2005年11月14日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 51 位内幕人士 · 33 位高管 · 17 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Stuart Essig | President and CEO | 2026年6月1日 A | 200000 | 0 | 0 | $0 |
| Mojdeh Poul | President & CEO | 2026年3月11日 A | 0 | 0 | 0 | $0 |
| Jan De Witte | President & CEO | 2024年11月1日 M | 23902 | 0 | 0 | $0 |
| Peter J Arduini | President & CEO | 2021年9月3日 M | 216713 | 0 | 0 | $0 |
| Lea Daniels Knight | EVP & Chief Financial Officer | 2026年7月3日 F | 45263 | 0 | 0 | $0 |
| Carrie L Anderson | Executive Vice President & CFO | 2022年7月1日 F | 57811 | 0 | 0 | $0 |
| Maureen B Bellantoni | Executive VP, CFO | 2007年4月2日 A | 4366 | 0 | 0 | $0 |
| Glenn Coleman | Executive Vice President & COO | 2022年7月1日 F | 34622 | 0 | 0 | $0 |
| Gerard S Carlozzi | Executive Vice President & COO | 2010年4月1日 A | 10713 | 0 | 0 | $0 |
| Chantal Veillon-Berteloot | EVP & CHRO | 2026年9月1日 F | 20772 | 0 | 0 | $0 |
| Harvinder Singh | EVP & President, SS | 2026年7月1日 A | 35422 | 0 | 0 | $0 |
| Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | 2026年7月1日 F | 34516 | 0 | 0 | $0 |
| Robert T. Davis JR. | EVP & President, TR&DT | 2026年7月1日 A | 66387 | 0 | 0 | $0 |
| Michael J. Mcbreen | EVP & Chief Commercial Officer | 2026年6月1日 A | 60743 | 0 | 0 | $0 |
| Michael David Hutchinson | EVP, Chief Legal Officer & Sec | 2026年3月11日 A | · | 0 | 0 | $0 |
| Eric Schwartz | EVP, Chief Legal Officer & Sec | 2025年3月11日 F | 56020 | 0 | 0 | $0 |
| Lisa Evoli | EVP & CHRO | 2023年3月10日 A | 18446 | 0 | 0 | $0 |
| Daniel L. Reuvers | CVP,PRES - CODMAN SPC SURGICAL | 2020年5月11日 M | 42473 | 0 | 0 | $0 |
| Kenneth Burhop | CORPVP,CHIEFSCIENTIFIC OFFICER | 2020年2月13日 A | 15100 | 0 | 0 | $0 |
| John Mooradian | Corp VP, Global Ops & Supp Chn | 2020年2月13日 A | 17542 | 0 | 0 | $0 |
| Judith Ogrady | CorpVP,Global Reg.Affairs | 2020年2月13日 A | 24276 | 0 | 0 | $0 |
| Joseph Vinhais | Corp VP,Quality&Transformation | 2019年9月11日 S | 8231 | 0 | 0 | $0 |
| Richard D. Gorelick | Corp VP, Gen Counsel & Sec | 2018年3月23日 F | 25752 | 0 | 0 | $0 |
| Mark A Augusti | CVP,PRES-ORTHO & TISSUE TECH | 2016年10月7日 F | 7962 | 0 | 0 | $0 |
| Deborah A Leonetti | Corp VP, Glbl Servs & Repair | 2015年5月8日 S | 8715 | 0 | 0 | $0 |
| Padma Thiruvengadam | Corp VP, Chief HR Officer | 2015年4月2日 F | 10229 | 0 | 0 | $0 |
| Brian Larkin | Corp VP, Pres.Gbl Spine &Ortho | 2015年4月2日 F | 6682 | 0 | 0 | $0 |
| John B Henneman III | CorpVP, CAO | 2014年8月25日 S | 34159 | 0 | 0 | $0 |
| Jerry E Corbin | Corp VP & Corporate Controller | 2014年7月1日 F | 7549 | 0 | 0 | $0 |
| Robert D Paltridge | Corp VP, Pres. Adv Woundcare | 2014年7月1日 F | 34480 | 0 | 0 | $0 |
| David B Holtz | Senior VP, Finance (1) | 2006年12月31日 F | 16374 | 0 | 0 | $0 |
| Don R Nociolo | Senior VP, Operations | 2006年3月15日 S | 18984 | 0 | 0 | $0 |
| Michael Piershbacher | Senior V.P.., R&D | 2004年3月3日 S | 0 | 0 | 0 | $0 |
| Renee Wonlai Lo | 董事 | 2026年5月7日 A | 35743 | 0 | 0 | $0 |
| Shaundra Clay | 董事 | 2026年5月7日 A | 41515 | 0 | 0 | $0 |
| Christian S Schade | 董事 | 2026年5月7日 A | 90034 | 0 | 0 | $0 |
| Keith Bradley | 董事 | 2026年5月7日 A | 88254 | 0 | 0 | $0 |
| Raymond G. Murphy | 董事 | 2024年5月9日 A | 54007 | 0 | 0 | $0 |
| Donald E Morel JR | 董事 | 2022年5月13日 A | 55753 | 0 | 0 | $0 |
| Rhonda Germany Ballintyn | 董事 | 2021年5月14日 A | 17162 | 0 | 0 | $0 |
| Lloyd Howell JR | 董事 | 2020年5月13日 A | 44638 | 0 | 0 | $0 |
| James M Sullivan | 董事 | 2018年5月17日 A | 62569 | 0 | 0 | $0 |
| Neal Moszkowski | 董事 | 2013年5月22日 A | 6936 | 0 | 0 | $0 |
| Thomas J Baltimore Jr | 董事 | 2012年5月17日 A | 22727 | 0 | 0 | $0 |
| Anne Vanlent | 董事 | 2012年5月17日 A | 8478 | 0 | 0 | $0 |
| David C Auth | 董事 | 2005年5月17日 A | · | 0 | 0 | $0 |
| Tru St Partnership, L.P. | 10% 所有者 | 2022年3月23日 S | 8515930 | 0 | 0 | $0 |
| Richard E Caruso | 10% 所有者 | 2020年6月18日 S | 10291205 | 0 | 0 | $0 |
| SOROS GEORGE | 10% 所有者 | 2005年11月21日 S | 2725300 | 0 | 0 | $0 |
| Jeffrey A Graves | · | 2026年5月7日 A | 41086 | 1 | 0 | $102150 |
| Barbara B Hill | · | 2026年5月7日 A | 151191 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
ETF持仓 由 45 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.12% | 46382 NS | 2026年7月31日 | N-PORT |
| IBRN · iShares Trust | 1.09% | 5220 SH | 2026年9月11日 | 每日 |
| PSCH · Invesco Exchange-Traded Fund Trus... | 0.58% | 62954 SH | 2026年10月2日 | 每日 |
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.50% | 7084 SH | 2026年10月2日 | 每日 |
| ESSC · Strategy Shares | 0.19% | 4086 NS | 2026年7月31日 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.16% | 76361 SH | 2026年8月19日 | 每日 |
| IHI · iShares Trust | 0.16% | 319452 SH | 2026年9月11日 | 每日 |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.13% | 141969 SH | 2026年8月19日 | 每日 |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.11% | 128628 SH | 2026年10月2日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.08% | 58920 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.07% | 120802 SH | 2026年10月2日 | 每日 |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.07% | 10513 SH | 2026年10月2日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.07% | 342338 NS | 2026年7月31日 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.06% | 233273 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 393933 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.04% | 32704 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.03% | 1748403 SH | 2026年9月11日 | 每日 |
| VBR · VANGUARD INDEX FUNDS | 0.03% | 960851 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.02% | 198881 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 32504 NS | 2026年7月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.01% | 102070 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 15062 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 769716 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.01% | 1512318 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.01% | 4261 SH | 2026年9月11日 | 每日 |
| SMDX · Tidal Trust III | 0.01% | 610 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 70522 NS | 2026年7月31日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.01% | 1004 SH | 2026年10月2日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.00% | 1247 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 81918 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 19275 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 3400 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4399 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 25248 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 91548 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 19842 SH | 2026年9月11日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.00% | 1313 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2108295 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5829 SH | 2026年8月19日 | 每日 |
| IJR · iShares Trust | · | 4077904 SH | 2026年9月10日 | 每日 |
| IJS · iShares Trust | · | 599789 SH | 2026年9月8日 | 每日 |
| IWN · iShares Trust | · | 642111 SH | 2026年9月11日 | 每日 |
| XJR · iShares Trust | · | 9216 SH | 2026年8月31日 | 每日 |
| ISCB · iShares Trust | · | 2961 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 14538 SH | 2026年9月11日 | 每日 |
IART 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
9 位分析师 · 2026-09-29平均目标 $19.56 +54.2%
同行比较(GICS 子行业) 关键指标与行业同行对比
财年依据,价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IART | · | -1.8 | 1.5% | -31.6% | -49.6% | · |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| AVR | $207M | -2.0 | -29.2% | -4921.3% | -300.5% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存,并会跟随您浏览所有股票。